Interestingly, our data are in agreement with previously published works, showing a reduction in cerebrospinal fluid ferroxidase activity from Alzheimer's and Parkinson's disease patients (Boll et al., 1999, 2008; Capo et al., 2008; Olivieri et al., 2011). This evidence concerns the gene CP and Parkinson disease.